Released: October 3, 2017

Defense Health Program
Psychological Health and Traumatic Brain Injury (PH/TBI) Research Program
Anticipated Funding Opportunities for Fiscal Year 2017 (FY17)

The FY17 PHTBIRP Program Announcement and General Application Instructions for the following award mechanism is anticipated to be posted on in October 2017. Pre-application and application deadlines will be available when the Program Announcements are released. This pre-announcement should not be construed as an obligation by the Government, and funding of research projects received in response to these Program Announcements is contingent on the availability of Federal funds appropriated for the PHTBIRP.

As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency J9, Research and Development Directorate, manages the Defense Health Program’s Research, Development, Test, and Evaluation appropriation. The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP).

Award Mechanism Eligibility Key Mechanism Elements Funding
Applied Behavior Analysis Clinical Study Award Investigators at or above the level of Associate Professor (or equivalent)
  • Supports a prospective clinical study that will evaluate the effectiveness of the tiered delivery model of Applied Behavior Analysis (ABA) for individuals diagnosed with Autism Spectrum Disorder (ASD). Findings from the clinical study should lead to a thorough and detailed understanding of the outcomes of ABA services delivered to participants diagnosed with ASD who receive tiered model ABA services.
  • The proposed clinical study should address the following list of variables (not all-inclusive): ASD symptom severity, cognitive and adaptive functioning, ABA services, services other than ABA utilized, and other demographic variables.
  • Although not required, investigators are strongly encouraged to include TRICARE beneficiaries diagnosed with ASD in the study population.
  • Maximum funding of $7,000,000 for combined direct and indirect costs.
  • Maximum period of performance is 4 years.

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions that will be available for electronic downloading from the website. The application package containing the required forms for each award mechanism will also be found on A listing of all CDMRP funding opportunities can be obtained on the website by performing a basic search using CFDA Number 12.420.

Applications must be submitted through the federal government’s single-entry portal, Submission deadlines are not available until the Program Announcements are released. For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at For more information about the PH/TBIRP or other CDMRP-administered programs, please visit the CDMRP website (

Point of Contact:

CDMRP Public Affairs

Last updated Thursday, May 26, 2022